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Abstract
Purpose—The few studies to date that have examined the relationship between hemoglobin and 
fracture risk have focused on low hemoglobin values. The present study examined hip fracture risk 
across the hemoglobin distribution in older non-Hispanic white adults from the third National 
Health and Nutrition Examination Survey (NHANES III, 1988–1994).
Methods—Hemoglobin was measured using a Coulter S-plus Jr.® (Coulter Electronics, Hialeah, 
FL) in 2122 non-Hispanic whites age 65 years and older. Hip fracture cases were identified using 
linked Medicare and mortality records obtained through 2007. Cox proportional hazards models 
were used to assess the best-fitting model and to estimate the hazards ratio (HR) for hip fracture 
by hemoglobin decile before and after adjusting for selected confounders.
Results—There were 239 hip fracture cases in the analytic sample. The best fitting model was 
quadratic. When compared to values in the middle of the distribution, those with hemoglobin in 
the lowest and highest deciles had increased hip fracture risk (HRlowest decile =2.96, 95% CI 1.44–
6.08; HRhighest decile = 2.06, 95% CI 1.09–3.92) after adjusting for age and sex. Both HRs 
remained significant after adjusting for additional confounders (HRlowest decile =2.24, 95% CI 
1.09–3.92; HRhighest decile = 2.37, 95% CI 1.35–4.16).
Conclusions—Both low and high hemoglobin values were associated with increased hip 
fracture risk. The mechanism underlying the relationship is not clear, but there was some 
suggestion that it may differ for low versus high hemoglobin.
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Introduction
Low hemoglobin has been linked to impaired bone turnover and poor bone strength in 
animal models [1–3], and a small number of studies in humans have reported an association 
between low hemoglobin and low BMD [4–6]. Although anemia is common in the elderly 
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[7], to date only two prospective studies and one retrospective open-cohort study have 
examined the relationship between low hemoglobin and risk of fracture or injurious falls that 
included fracture [8–10]. All three studies found low hemoglobin increased risk of fracture 
or injurious falls, but the two prospective studies differed as to whether the relationship 
remained significant in women after adjusting for selected confounders. In addition, these 
studies did not examine the possible role of common causes of anemia in the elderly [7], 
such as biochemically-defined iron or folate deficiency, inflammation, or renal 
insufficiency, as possible mechanisms underlying the low hemoglobin-fracture risk 
relationship.
The previous studies of hemoglobin and risk of fracture or injurious falls focused on risk 
among those with low hemoglobin, but high hemoglobin levels have also been associated 
with poor outcomes, including mobility disability and mortality [11–13]. The present study 
used linked Medicare and mortality data for non-Hispanic white respondents age 65 years 
and older from the third National Health and Nutrition Examination Survey (NHANES III) 
to assess hip fracture risk across the hemoglobin distribution. The relationship between 
hemoglobin and hip fracture risk was examined before and after adjusting for selected 




The baseline data for this study came from NHANES III, which was conducted in 1988–
1994 by the National Center for Health Statistics (NCHS), Centers for Disease Control and 
Prevention, to assess the health and nutritional status of a representative sample of the non-
institutionalized, civilian population of the U.S. Data were collected via household 
interviews and physical examinations conducted in specially equipped mobile examination 
centers [14]. All procedures in NHANES III were approved by the NCHS Institutional 
Review Board, and written informed consent was obtained from all subjects [14].
NHANES III was designed to provide statistically reliable estimates for three race/ethnic 
groups: non-Hispanic whites (NHW), non-Hispanic blacks (NHB), and Mexican Americans 
(MA). Race and ethnicity were self-reported.
NHANES III was linked with data from mortality files created by NCHS and with Medicare 
enrollment and claims records in order to provide a follow-up component to the survey. 
Vital status of study participants from the date of their participation in NHANES III through 
December 31, 2006 was determined from the NHANES III Linked Mortality File [15]. This 
file contains mortality follow-up data based on a probabilistic match between the eligible 
NHANES III sample and the National Death Index (NDI). Vital status for the year 2007 was 
based on status from the Medicare Denominator file [16].
Medicare enrollment and utilization data were available for NHANES respondents who 
agreed to provide personal identification [16]. There were 8,585 persons in NHANES III 
who were age 65 years and older at the time of the Medicare linkage, of which 8,303 (97%) 
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were eligible to be linked with Medicare. Of these 8,303 eligible respondents, 8,024 (97%) 
were successfully validated and matched with Medicare administrative records. Medicare 
claims data were provided from respondents who participated in fee-for-service care from 
1991 through 2007. Claims data were not available for those in Medicare managed care 
plans. In the present study, claims data from the following files were used: Medicare 
Provider Analysis and Review (MEDPAR) Inpatient Hospital Stay File/Skilled Nursing 
Facility (SNF) File, Carrier Standard Analytic File, and Outpatient Standard Analytic File. 
The Medicare Denominator files were used to restrict the analytic sample to those who were 
successfully matched to the Medicare claims data, to obtain information about enrollment in 
managed care plans and to provide vital status for the year 2007.
The analytic sample in this study was restricted to respondents aged 65 years and older at 
the time of their NHANES interview at baseline. Preliminary analyses indicated that a 
significant interaction in the hemoglobin-hip fracture relationship existed by race/ethnicity, 
but there were insufficient hip fracture cases among non-Hispanic blacks and Mexican 
Americans to permit separate analyses in those groups. As a result, the analytic sample was 
also restricted to non-Hispanic whites.
Of the 3407 non-Hispanic white individuals age 65 years and older who were interviewed in 
NHANES III, 2122 (62%) remained in the analytic sample after exclusions had been made. 
Respondents were excluded if they: a) were interviewed but not examined in the mobile 
examination centers (n=867); b) had a prior hip fracture at baseline (n=121); c) were hip 
fracture cases with concurrent codes indicating care for a previous fracture or other bone 
diseases (n=24); d) were not eligible for linkage to the CMS Medicare denominator file2 
(n=40); e) were eligible but could not be linked to the CMS Medicare denominator file 
(n=64); f) were enrolled in managed care at the time of the baseline examination (n=78); g) 
were decedents whose death certificate lacked cause of death information (n=8); or i) were 
missing hemoglobin (n=83).
Descriptive characteristics and risk factors were compared between non-Hispanic white 
respondents who were retained versus excluded from the analytic sample to assess the 
potential for nonresponse bias in the study results. The excluded respondents were more 
likely to be women and have lower hemoglobin, femur neck BMD and BMI than 
respondents who were included. They were also more likely to have renal insufficiency, be 
less active, and self-report having been told by a physician that they had non-skin cancer.
Fracture case identification—Hip fracture risk was examined in the present study 
because results from the Women’s Health Initiative from Chen et al [8] indicated that, of the 
various skeletal sites examined, the strongest relationship between hemoglobin and fracture 
risk occurred for hip fracture [8]. Hip fracture cases were identified using methods 
developed by Ray et al [17] and Taylor et al [18]. International Classification of Disease 
(ICD), Healthcare Common Procedure Coding System (HCPCS) or Current Procedural 
Terminology (CPT) codes for the years 1991–2007 [19, 20] were used to define cases. Cases 
2Respondents were ineligible for linkage to CMS administrative records if they were missing key identification data and/or if they did 
not provide their Social Security or Medicare number at baseline or did not have a Social Security number verified by the Social 
Security Administration's Enumeration Verification System.
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identified from the MedPAR Hospital Inpatient/Skilled Nursing Facility files were based on 
ICD-9 diagnosis codes for any of 10 discharge diagnoses. Cases identified from the Carrier 
file were based on ICD-9 diagnosis codes for any of 5 diagnoses and a concurrent relevant 
HCPCS/CPT procedure code. Cases identified from the Outpatient File were based on 
relevant ICD-9 diagnosis codes for any of 11 diagnoses or on relevant ICD-9 surgical 
procedure codes; both required a concurrent relevant HCPCS/CPT code for any of 45 
procedure variables. Respondents with codes indicating care of previous fracture or other 
bone diseases, neoplasm or hip arthroplasty for arthritis were excluded from the analyses. 
Detailed information describing the definition of hip fracture cases from Medicare records, 
including specific codes, have been published elsewhere [21].
Cause of death information from the NHANES III Linked Mortality File was also used to 
identify hip fracture. Persons with an ICD-9 code 820 or ICD-10 code S72.0-S72.2 listed as 
an underlying or multiple cause of death were defined as hip fracture cases (n=22 in the 
analytic sample).
A total of 239 hip fracture cases were identified in the analytic sample used in the present 
study. The majority of fracture cases (n=193, or 81% of hip fracture cases) in the analytic 
sample had diagnoses consistent with hip fracture on records from more than one file. Of the 
230 hip fracture cases that were identified via inpatient hospital records, 205, or 89% also 
had relevant surgical codes for hip fracture.
Hemoglobin and hematocrit—Hemoglobin and hematocrit were measured on venous 
blood in the mobile examination centers using a Coulter S-plus Jr.® (Coulter Electronics, 
Hialeah, FL). Hematocrit was included in the present study to examine the prevalence of 
erythrocytosis, or excess red blood cells. Definitive erythrocytosis was defined as hematocrit 
> 60% for males and >56% for females, while suspected erythrocytosis was defined as 
hematocrit >51% for males and >48% for females [22].
Potential confounding variables—Potential confounding variables examined in the 
present study included factors that have previously been linked with hip fracture risk or with 
hemoglobin, including important causes of anemia among the elderly in the US [7] and 
secondary causes of elevated hemoglobin associated with erythrocytosis [22].
Biochemical indicators of iron, folate and vitamin B12 status: Serum biochemical 
indicators of iron, folate, and vitamin B12 status were measured at the National Center of 
Environmental Health, CDC, Atlanta GA. Details of the methods have been published 
elsewhere [23]. Briefly, serum ferritin was measured using a two site immunoradiometric 
assay (IRMA) (BioRad Laboratories, Hercules, CA). Transferrin saturation was calculated 
as serum iron divided by total iron-binding capacity, as measured by a CDC modification of 
the automated Technicon AAII-25® ferrozine colorimetric method (Alpkem TFA® analyzer; 
Alpkem, Clackamas, OR). Free erythrocyte protoporphyrin was measured in whole blood by 
fluorescence extraction using a modification of the Sassa method. Serum and red cell folate 
and serum vitamin B12 were measured with a radioimmunoassay kit ((QuantaPhase-I and 
QuantaPhase-II Folate Radioassay Kit, Bio-Rad Laboratories, Hercules, CA). Serum vitamin 
B12 was only measured during the second phase of NHANES III (1991–1994).
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Iron deficiency was defined as having two or more of the following conditions: serum 
ferritin< 12 ng/mL, transferrin saturation< 15%, or free erythrocyte protoporphyrin > 70 
[24]. Low folate status was defined as serum folate < 3 ng/mL or red cell folate < 140 
ng/mL, while low vitamin B12 status was defined as serum vitamin B12 < 200 pg/mL [25].
Inflammation: Respondents were considered to have inflammation if they met any one of 
the following three conditions: serum C-reactive protein (CRP) > 1 mg/dL; plasma 
fibrinogen > 400 g/L, or low serum iron (defined as a value < 60 μg/dL) without evidence of 
iron deficiency as described in the previous section. The latter approach was used by 
Guralnik et al [7] to define anemia of chronic inflammation in their study of important 
causes of anemia in older persons. Serum CRP was measured at the University of 
Washington, Seattle WA by latex-enhanced nephelometry, while plasma fibrinogen was 
measured at White Sands Research Center, Alamogordo NM by comparing the clotting time 
of the plasma specimen with the clotting time of a standardized fibrinogen preparation [23].
Thyroid function: Serum thyroid stimulating hormone (TSH) was measured via a 
chemiluminescence immunometric assay kit (Nichols Instsitute Diagnostics, San Juan 
Capistrano, CA) at the University of Southern California Endocrine Services laboratory, Los 
Angeles CA.
Bone density and body mass index: Femur neck bone mineral density (BMD) was 
measured by dual energy x-ray absorptiometry (Hologic QDR 1000, Bedford MA) [26]. 
Body weight was measured to the nearest 0.01 kg using an electronic load cell scale, and 
standing height was measured with a fixed stadiometer. Body mass index (BMI) was 
calculated as body weight (kilograms) divided by height (meters squared).
Renal insufficiency: Renal insufficiency was defined using the approach of Guralnik et al 
[7]. Specifically, creatinine clearance was estimated using the Cockroft-Gault equation [27]:
Values for women were reduced by 15% [27]. Serum creatinine was measured on a Hitachi 
model 737 multichannel analyzer (Boehringer Mannheim Diagnostics, Indianapolis IN) by 
the Jaffe reaction. Renal insufficiency was defined as an estimated creatinine clearance < 30 
mL/min.
Self-reported diagnosis of selected diseases: Variables related to selected heart or 
respiratory conditions and cancer were included as possible covariates since they may be 
secondary causes of high hemoglobin or erythrocytosis [22]. Specifically, self-reported 
doctor’s diagnosis of heart conditions, respiratory conditions, or cancer other than skin 
cancer were based on positive responses to the question: “Has a doctor ever told you that 
you had”: a) heart attack, congestive heart failure, or stroke; b) asthma, bronchitis, 
emphysema or hay fever; and c) cancers other than skin cancer.
Looker Page 5













Falls and timed chair stand: Falls were defined as the number of times in the previous 12 
months that the respondent reported falling and landing on the floor or hitting an object. 
Timed chair stand was defined as time in seconds to rise five times from an armless chair 
[28].
Lifestyle behaviors: Respondents rated their current physical activity level as more active, 
less active, or about the same when compared to others of their same age and sex. 
Respondents also rated their general health status as poor, fair, good, very good or excellent. 
Cigarette use was categorized as ever smoked versus never smoked based on responses to 
questionnaire items asking “Have you ever smoked at least 100 cigarettes in your lifetime?” 
Alcohol users were defined as respondents who self-reported that they usually consumed 
three or more drinks per day when they drank alcohol.
Statistical Analysis
All analyses were performed using SAS 9.3 (SAS Institute, Cary NC) and SUDAAN 
software [29] for analysis of data from complex sample surveys. Descriptive characteristics 
and risk factors at baseline were screened for possible inclusion as confounders in 
subsequent analysis by using linear regression and chi-square analyses to examine their 
relationship with hip fracture status and hemoglobin (expressed as a continuous variable and 
also grouped into two categories).
Cox proportional hazards models were used to model time to event and to calculate 
estimates of the hazard ratio (HR) of hip fracture by hemoglobin while controlling for all 
risk factors simultaneously and accounting for unequal length of follow-up. Length of 
follow-up was calculated for hip fracture cases as the time from date of examination to date 
of diagnosis or procedure for those cases identified by Medicare records or date of death for 
those cases identified by death certificates. Follow-up time for non-cases was calculated as 
time from baseline exam to date of death for decedents, date of entry into managed care for 
those who enrolled in a Medicare managed care program after their baseline examination, or 
end of follow-up on December 31, 2007 for those who did not fall into the first two 
categories. A test of the proportional hazard assumption indicated no significant trend in HR 
with time (p=0.15), which suggests the assumption was not violated.
Preliminary analyses to assess significant interactions in the hemoglobin-hip fracture 
relationship by demographic characteristics identified a significant interaction by race/
ethnicity, but not by age or sex in the non-Hispanic white sample, so subsequent analyses 
were performed for the total non-Hispanic white sample after adjusting for age and sex.
Preliminary analyses were also performed to evaluate the shape of the relationship between 
hemoglobin and fracture risk by fitting a series of Cox models that successively included 
linear, quadratic and cubic terms for hemoglobin in addition to adjusting for age and sex 
[30]. The best model was chosen based on the statistical significance of the linear, quadratic 
or cubic term for hemoglobin. Results of these analyses indicated that the relationship 
between hemoglobin and hip fracture risk was quadratic.
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To further evaluate the shape of the relationship, the hemoglobin distribution was divided 
into sex-specific deciles, in order to use the smallest quantiles possible while still 
maintaining at least 10 hip fracture cases per quantile. The goal was to obtain reasonably 
stable estimates that could be used to visualize the relationship without making assumptions 
about its exact shape or location of possible inflection points. HRs were plotted using the 
fifth hemoglobin decile as the initial reference group (Figure 1). In subsequent analyses, the 
fifth and sixth deciles were combined to form the reference group in order to increase the 
number of hip fracture cases in that category. Cox proportional hazards models were used to 
calculate HRs for hip fracture by hemoglobin deciles after adjusting for age and sex (base 
model) as well as after adjusting simultaneously for all additional risk factors that were 
significantly related to fracture status or hemoglobin (full model).
The potential role of the risk factors used in the full model to explain the hemoglobin-hip 
fracture relationship was evaluated by examining the change in the HR for the hemoglobin 
deciles when tested in the same model after adding each risk factor singly to the base Cox 
model, and comparing the HR for the base + individual risk factor with the HR for the base 
model alone.
Secondary analyses were performed to assess the impact of including serum ferritin in the 
multivariate Cox model as a continuous variable, since elevated ferritin can indicate 
inflammation, which can reduce hemoglobin values [7]. High ferritin has also been 
associated with low BMD [31]. HRs for the model that included ferritin as a continuous 
variable were compared with HRs from the main analysis, where low ferritin was used as 
part of the definition of iron deficiency. Secondary analyses were also conducted in women 
only, in order to facilitate a comparison with results from previous studies of hemoglobin 
and fracture risk [8, 9]. Finally, secondary analyses were performed to examine the effect of 
including serum vitamin B12 deficiency in the Cox model in addition to iron and folate 
deficiency, since vitamin B12 deficiency can result in anemia. This analysis was limited to 
1051 respondents in the analytic sample who were examined in the second phase of 
NHANES III (1991–1994), and thus had serum vitamin B12 data. HRs for the multivariate 
model that included vitamin B12 deficiency in addition to iron and folate deficiency were 
compared with HRs from the multivariate model without vitamin B12 deficiency in this 
analytic subsample.
Results
Table 1 compares selected risk factors at baseline by hip fracture and hemoglobin status. 
Hemoglobin was divided into two categories (above/below the median) so that results for 
hemoglobin and hip fracture status could be summarized in a single table. Variables that 
differed significantly either by hip fracture status or hemoglobin group included age, sex, 
femur neck BMD, BMI, timed chair stands, iron or folate deficiency, inflammation, renal 
insufficiency, and smoking. These variables were subsequently included in the full 
multivariate Cox models used to assess hip fracture risk by hemoglobin status.
The prevalence of suspected erythrocytosis, defined as a hematocrit value >51% for males 
and > 48% for females, was 1.2% (data not shown). No individuals in the analytic sample 
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met the criteria for definitive erythrocytosis (hematocrit > 60% for males and > 56% for 
females).
HRs by hemoglobin categories are shown in Table 2 after adjusting for age and sex (base 
model) and after adjusting for the significant confounders identified as well (full model). 
When compared to the reference group (5th and 6th decile), those with hemoglobin in both 
the lowest and highest deciles had significantly increased hip fracture risk after adjusting for 
age and sex. The HR for hemoglobin decile 9 was also significantly higher than the 
reference group. Adjusting for the additional risk factors reduced the HR point estimate for 
the lowest hemoglobin decile, but it remained statistically significant. Adjusting for the 
additional risk factors increased the HR point estimate somewhat in the highest hemoglobin 
decile.
Table 3 summarizes results from analyses performed to examine the potential contribution 
of the risk factors used in the full model on the hemoglobin-hip fracture relationship in more 
detail. The impact of adding the risk factors singly was tested for all hemoglobin deciles in 
the same model, but the results are shown only for the first and tenth hemoglobin deciles 
because those deciles had the largest number of hip fracture cases. In decile 1, adding femur 
neck BMD, BMI and iron/folate deficiency separately to the base model each lowered the 
HR by approximately 0.3–0.4 units, suggesting that they had a similar effect on hemoglobin-
hip fracture risk relationship in this decile. Adding smoking to the base model increased the 
HR in decile 1 by approximately 0.2 units, while the remaining risk factors changed the HR 
by 0.14 units or less. In hemoglobin decile 10, adding FNBMD to the base model increased 
the HR by 0.6 units, while the other variables changed the base model HR by 0.14 units or 
less. It is important to note that, while adding the risk factors to the base model changed the 
HR point estimates by these amounts, the 95% CI for the HRs from the base + one 
additional risk factor models overlapped with the base model HRs in each decile group.
HRs obtained from the secondary analysis that included serum ferritin in the multivariate 
Cox model as a continuous variable were similar to those obtained in the main analyses 
which had focused on low ferritin only (data not shown). The relationship between 
hemoglobin and hip fracture risk also remained significant before and after adjusting for the 
selected risk factors when the analyses were limited to women only (data not shown). 
Finally, HRs for the multivariate model which included serum B12 deficiency were similar 
to those from the multivariate model without vitamin B12 deficiency (data not shown). 
Because conclusions were unchanged in all three sets of secondary analyses, only results 
from the main analyses are shown in the tables.
Discussion
Hemoglobin was significantly related to hip fracture risk in a nonlinear fashion among the 
older US white adults examined in the present study before and after adjusting for several 
potential confounding factors. The relationship appeared to be U-shaped, as both low and 
high hemoglobin values were associated with higher hip fracture risk than hemoglobin 
values in center of the distribution. The HRs for high or low hemoglobin were similar in 
magnitude to those reported for several of the risk factors currently used in the FRAX© 
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model, such as femur neck BMD, previous fracture, or smoking [32–35]. U-shaped and J-
shaped relationships have been reported previously between hemoglobin and mortality [11–
13] or mobility disability [11], but the present study appears to be the first to report a U-
shaped relationship between hemoglobin and fracture risk. Previous studies of the 
hemoglobin-fracture risk relationship focused on risk in anemic versus non-anemic women 
[8, 10] or used a linear model in which the highest hemoglobin tertile was the reference 
group [9].
The mechanism through which hemoglobin affects hip fracture risk is not clear. Results 
from the present study suggest that different factors may play a role at the two tails of the 
hemoglobin distribution. For example, adjusting for various risk factors reduced the 
magnitude of the point estimate for the hemoglobin in the lowest decile when compared to 
hemoglobin in the middle of the distribution, but increased the HR point estimate in the 
highest hemoglobin decile. The analyses in which risk factors were added singly to the base 
model also suggested different roles for the risk factors at low versus high hemoglobin. In 
the lowest decile, adding femur neck BMD, BMI, and iron/folate deficiency each attenuated 
the base model HR point estimate by a similar amount, while the other risk factors had 
smaller separate impacts. In contrast, adjusting separately for BMI or iron/folate deficiency 
had little impact on the base model HR estimate in the highest hemoglobin decile, while 
adjusting for femur neck BMD increased the base model HR point estimate. It is also 
interesting to note that, of the important causes of anemia in older person that could be 
considered in this study, iron/folate deficiency appeared to have more impact than 
inflammation or renal insufficiency on the hemoglobin-hip fracture relationship in the 
lowest HB group. However, the HR estimates for these “base plus single risk factor” models 
had 95% CI that overlapped the base model HR, which precludes firm conclusions.
Some have postulated that low hemoglobin is linked to poor outcomes directly via its effect 
on oxygen delivery to tissues [36], while others have suggested that, rather than being 
causative, low hemoglobin reflects poor general health [37]. Some data suggest anemia has 
an independent effect on mortality and that correcting anemia may reduce morbidity from 
cardiovascular or kidney disease and certain cancers [38]. Anemia may also act together 
with common comorbidities to increase risk of outcomes like frailty. Anemia has been 
linked to a number of potential pathways to fracture, including falls, reduced cognition, 
decreased physical activity and decreased BMD [36].
Mechanisms linking high hemoglobin to poor outcomes have also not been clearly 
identified. High hemoglobin is related to blood viscosity, which may compromise 
cardiovascular function by causing endothelial damage in blood vessels. The resulting 
inflammation could possibly impact bone in a negative manner. Blood viscosity could not be 
assessed in the present study, but, based on hematocrit criteria, no respondents had definitive 
erythrocytosis and only 1% had suspected erythrocytosis. Thus, excessive blood viscosity 
seems unlikely to explain the higher fracture risk seen among those with high hemoglobin. 
Inflammation also seems unlikely to have played an important role, since adjusting for 
inflammation did not noticeably decrease HRs in the higher hemoglobin categories. High 
hemoglobin can also be a secondary outcome of various heart, renal and lung conditions 
[22], which in turn could potentially play a role in the link between high hemoglobin and 
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fracture. Renal insufficiency and self-reported heart, lung and non-skin cancer diagnoses 
were among the variables considered for inclusion in the full model in the present study, but 
only renal insufficiency met the criteria of being significantly related to either hip fracture 
status or hemoglobin. Its inclusion in in the full model had little effect on the HR for the 
highest hemoglobin group.
In addition to finding a nonlinear relationship between hemoglobin and hip fracture risk, 
results from the present study differed from two of the previous studies on this topic 
regarding differences in the relationship by some demographic variables. For example, 
Jorgensen et al [9] reported that the relationship between hemoglobin and fracture risk was 
no longer significant in women after adjusting for confounding variables, but adjusting for 
confounders did not remove the relationship among women in the present study. Use of 
different confounders and fracture outcomes in the two studies could potentially explain 
these differences. The present study also found a significant interaction in the hemoglobin-
fracture relationship by race/ethnicity, whereas Chen et al [9] found no race/ethnic 
differences in the relationship. The reason for these different findings is not clear, but race/
ethnic differences in the relationship between hemoglobin and other outcomes, such as 
mortality or mobility disability [39–41], have been reported. Finally, Chen et al [8] noted 
that the hemoglobin-fracture relationship was stronger in women over age 70 than in 
younger women, but no difference by age was found in the present study when results were 
compared by age 65–79 years versus 80+ years. Use of different age categories in the two 
studies could potentially explain the difference in findings by age.
Strengths of the present study include use of a cohort derived from a nationally 
representative sample and the availability of variables that have been identified as important 
causes of both low and high hemoglobin levels. However, not all relevant variables could be 
considered in the study. For example, genetic disorders that lead to high hemoglobin were 
not assessed in NHANES III, and data for secondary causes of elevated hemoglobin, such as 
certain cardiovascular and respiratory conditions or selected cancers, were limited to self-
reported data for broad categories of cancer and heart or lung conditions. The very low 
prevalence of erythrocytosis observed in the study sample suggests that the genetic disorders 
were unlikely to play an important role in explaining the observed relationship between high 
hemoglobin and hip fracture risk, but the self-reported data on heart, lung and non-skin 
cancers may have been too broad to capture the relevant information for those conditions. 
Living at an altitude over 3000 feet can also elevate hemoglobin [42], but there were only 
two data collection locations in NHANES III over this altitude, so altitude appears unlikely 
to have played a significant role in the study results. Serum vitamin B12 data were not 
available for the entire analytic sample, but results from the secondary analyses using the 
serum vitamin B12 subsample from second phase of NHANES III suggested that its 
inclusion would not have significantly altered study results. Finally, the number of hip 
fracture cases in each hemoglobin decile was small, which likely limited power to detect 
significant relationships.
Other limitations include hip fracture identification based on Medicare and death records 
without confirmation by x-ray. However the vast majority of cases had codes indicating hip 
fracture diagnosis on multiple sources of Medicare records, and hospitalized cases had 
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concurrent codes indicating relevant surgical procedures for hip fracture. A small number of 
hip fracture cases may be mistakenly classified as non-cases due to lack of Medicare records 
prior to 1991--we previously estimated that 13 undetected hip fracture cases may have 
occurred during 1988–90 [21]. In addition, study results apply only to the segment of the 
population ages 65+ years that was not institutionalized at baseline and participated in 
Medicare fee-for-service programs. Exclusions for missing data or loss to follow-up were 
also made. Excluded respondents were more likely to have lower hemoglobin and lower 
BMD than respondents in the analytic sample, which could impact the generalizability of 
results for hip fracture risk among those with low hemoglobin. Nonrespondents were also 
more likely to be female, and have lower BMI and other selected characteristics associated 
with poor health than respondents who were included. Thus, although based on a cohort 
derived from nationally representative sample at baseline, results from the present study 
cannot be generalized to the entire adult population over age 65 years.
In summary, both high and low hemoglobin values were related to increased hip fracture 
risk in older non-Hispanic whites. Reasons for this relationship are unclear, although there 
was some suggestion that the factors underlying this relationship may differ for low versus 
high hemoglobin. Others have noted that, despite being relatively common, anemia in older 
persons may be overlooked in clinical settings and have called for more research and better 
guidelines for addressing this condition in this age group [36–38, 43]. Results from the 
present study support a focus on both low and high hemoglobin levels among older persons.
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Hazard ratio (HR) for hip fracture by sex-specific hemoglobin decile
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Change in hazard ratio (HR) for risk factors added singly to base model for first and tenth hemoglobin decile, 
Non-Hispanic white adults age 65+ years, NHANES III follow-up
Hemoglobin decile HR LL UL Difference from base model HR*
Decile 1
Base model (adjusted for age and sex) 2.96 1.44 6.08
 Base model + smoking 3.14 1.51 6.56 0.18
 Base model + femur neck BMD 2.57 1.29 5.12 −0.39
 Base model + BMI 2.66 1.29 5.48 −0.30
 Base model + timed chair stand 2.96 1.40 6.22 0
 Base model + iron/folate deficiency 2.61 1.27 5.37 −0.35
 Base model + inflammation 2.97 1.49 5.92 0.01
 Base model + renal impairment 2.82 1.34 5.90 −0.14
Decile 10
Base model (adjusted for age and sex) 2.06 1.09 3.92
 Base model + smoking 1.97 1.04 3.74 −0.09
 Base model + femur neck BMD 2.65 1.49 4.71 0.59
 Base model + BMI 2.20 1.19 4.06 0.14
 Base model + timed chair stand 1.94 1.00 3.73 −0.12
 Base model + iron/folate deficiency 2.05 1.09 3.84 −0.01
 Base model + inflammation 2.06 1.09 3.92 0
 Base model + renal impairment 2.06 1.09 3.91 0
*
Hazard ratio for base model + risk factor minus hazard ratio for base model only.
LL=lower limit of 95% confidence interval; UL=upper limit of 95% confidence interval
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